Evidence map›Paper›PMID 26040313›Full record

ArticleMalaria journal2015

Use of Plasmodium falciparum culture-adapted field isolates for in vitro exflagellation-blocking assay.

Louis-Jérôme Leba, Lise Musset, Stéphane Pelleau, Yannick Estevez, Caroline Birer, Sébastien Briolant, Benoit Witkowski, Didier Ménard, Michael J Delves, Eric Legrand and 2 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. AScience advances · 2023
    Article
  3. Article
  4. Viability and Infectivity ofFrontiers in cellular and infection microbiology · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Louis-Jérôme LebaLaboratoire de Parasitologie, Institut Pasteur de la Guyane, Cayenne, French Guiana, France. louisjerome973@hotmail.fr.
Lise MussetLaboratoire de Parasitologie, Institut Pasteur de la Guyane, Cayenne, French Guiana, France. lmusset@pasteur-cayenne.fr.
Stéphane PelleauLaboratoire de Parasitologie, Institut Pasteur de la Guyane, Cayenne, French Guiana, France. spelleau@pasteur-cayenne.fr.
Yannick EstevezLaboratoire ECOFOG (Ecology of Guiana Forests) UMR8172 CNRS-INRA-CIRAD-AgroParisTech-Université des Antilles-Université de la Guyane, French Guiana, France. yannick.estevez@ecofog.gf.
Caroline BirerLaboratoire ECOFOG (Ecology of Guiana Forests) UMR8172 CNRS-INRA-CIRAD-AgroParisTech-Université des Antilles-Université de la Guyane, French Guiana, France. carolinebirer@yahoo.fr.
Sébastien BriolantLaboratoire de Parasitologie, Institut Pasteur de la Guyane, Cayenne, French Guiana, France. sbriolant@pasteur-cayenne.fr.
Benoit WitkowskiMalaria Molecular Epidemiology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia. bwitkowski@pasteur-kh.org.
Didier MénardMalaria Molecular Epidemiology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia. dmenard@pasteur-kh.org.
Michael J DelvesDepartment of Life Sciences, Imperial College, London, UK. michael.delves@imperial.ac.uk.
Eric LegrandLaboratoire de Parasitologie, Institut Pasteur de la Guyane, Cayenne, French Guiana, France. eric.legrand@pasteur.fr.
Christophe DuplaisLaboratoire ECOFOG (Ecology of Guiana Forests) UMR8172 CNRS-INRA-CIRAD-AgroParisTech-Université des Antilles-Université de la Guyane, French Guiana, France. christophe.duplais@ecofog.gf.
Jean PopoviciLaboratoire de Parasitologie, Institut Pasteur de la Guyane, Cayenne, French Guiana, France. jean.o.popovici@gmail.com.
University of French Guiana · GFEcologie des Forêts de Guyane · GFInstitut Pasteur du Cambodge · KHImperial College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA major requirement for malaria elimination is the development of transmission-blocking interventions. In vitro transmission-blocking bioassays currently mostly rely on the use of very few Plasmodium falciparum reference laboratory strains isolated decades ago. To fill a piece of the gap between laboratory experimental models and natural systems, the purpose of this work was to determine if culture-adapted field isolates of P. falciparum are suitable for in vitro transmission-blocking bioassays targeting functional maturity of male gametocytes: exflagellation.

methodsPlasmodium falciparum isolates were adapted to in vitro culture before being used for in vitro gametocyte production. Maturation was assessed by microscopic observation of gametocyte morphology over time of culture and the functional viability of male gametocytes was assessed by microscopic counting of exflagellating gametocytes. Suitability for in vitro exflagellation-blocking bioassays was determined using dihydroartemisinin and methylene blue.

resultsIn vitro gametocyte production was achieved using two isolates from French Guiana and two isolates from Cambodia. Functional maturity of male gametocytes was assessed by exflagellation observations and all four isolates could be used in exflagellation-blocking bioassays with adequate response to methylene blue and dihydroartemisinin.

conclusionThis work shows that in vitro culture-adapted P. falciparum field isolates of different genetic background, from South America and Southeast Asia, can successfully be used for bioassays targeting the male gametocyte to gamete transition, exflagellation.

Indexed as

Malaria, FalciparumParasitologyPlasmodium falciparumReproduction

Identifiers

PMID26040313
PMCPMC4464717
OpenAlexW1573169282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.